RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$810M
1-Year Est. Return
30.2%
This Fund
S&P 500
1 Year Est. Return
+30.2%
AUM
$1.07B
AUM Growth
+$166M
(+18%)
Holding
105
Top Buys
| 1 | +$17.2M | |
| 2 | +$13.3M | |
| 3 | +$11.4M | |
| 4 |
Nuvalent
NUVL
|
+$10.9M |
| 5 |
Vera Therapeutics
VERA
|
+$10.3M |
Top Sells
| 1 | +$19M | |
| 2 | +$14.8M | |
| 3 | +$13.2M | |
| 4 |
Cytokinetics
CYTK
|
+$13.1M |
| 5 |
Ionis Pharmaceuticals
IONS
|
+$11.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRUS
101
DELISTED
Merus
MRUS
| – | – |
-53,500
|
|
||
102
Ultragenyx Pharmaceutical
RARE
$2.16B
| – | – |
-119,400
|
|
||
103
Bio-Techne
TECH
$8.14B
| – | – |
-15,000
|
|
||
104
Universal Health Services
UHS
$8.79B
| – | – |
-12,000
|
|
||
105
United Therapeutics
UTHR
$23.3B
| – | – |
-8,000
|
|